miR-141-3p suppresses development of clear cell renal cell carcinoma by regulating NEK6-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

miR-141-3p suppresses development of clear cell renal cell carcinoma by regulating NEK6

Published:2021-08-11 Issue:1 Volume:33 Page:e125-e133
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Liu Yifei,Fu Wenqiang,Yin Feng,Xia Lianjie,Zhang Yubo,Wang Baocun,Li Tengfei,Zhang Tingting,Cheng Ling,Wei Yanbing,Gao Bin

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference21 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.;Bray;CA Cancer J Clin,2018

2. Kidney cancer.;Johansson;Semin Cancer Biol,2013

3. Kidney cancer: the next decade.;Turajlic;J Exp Med,2018

4. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases.;Rupaimoole;Nat Rev Drug Discov,2017

5. MiR-141-3p inhibits cell proliferation, migration and invasion by targeting TRAF5 in colorectal cancer.;Liang;Biochem Biophys Res Commun,2019

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NEK6 dampens FOXO3 nuclear translocation to stabilize C-MYC and promotes subsequent de novo purine synthesis to support ovarian cancer chemoresistance;Cell Death & Disease;2024-09-10

2. Prognostic value and immune infiltration of the NEK family in clear cell renal cell carcinoma;Medicine;2024-07-19

3. Identification of a signature of histone modifiers in kidney renal clear cell carcinoma;Aging;2024-06-17

4. microRNA-141-3p Suppressed the Progression of the Clear Cell Renal Cell Carcinoma by Targeting Transforming Growth Factor Beta 2 Gene Expression;DNA and Cell Biology;2024-05-01

5. Regulation of overexpression lncRNA ATP2B1-AS1 on lung adenocarcinoma progression;Journal of Cardiothoracic Surgery;2024-02-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3